Annual Operating Expenses
$70.46 M
+$25.61 M+57.09%
December 31, 2024
Summary
- As of March 10, 2025, AQST annual total operating expenses is $70.46 million, with the most recent change of +$25.61 million (+57.09%) on December 31, 2024.
- During the last 3 years, AQST annual operating expenses has fallen by -$62.00 thousand (-0.09%).
- AQST annual operating expenses is now -26.13% below its all-time high of $95.38 million, reached on December 31, 2018.
Performance
AQST Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$20.93 M
+$3.53 M+20.30%
December 31, 2024
Summary
- As of March 10, 2025, AQST quarterly total operating expenses is $20.93 million, with the most recent change of +$3.53 million (+20.30%) on December 31, 2024.
- Over the past year, AQST quarterly operating expenses has stayed the same.
- AQST quarterly operating expenses is now -49.77% below its all-time high of $41.66 million, reached on June 30, 2018.
Performance
AQST Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
AQST Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +57.1% | 0.0% |
| 3 y3 years | -0.1% | +97.8% |
| 5 y5 years | -17.0% | +97.8% |
AQST Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.1% | +57.1% | at high | +97.8% |
| 5 y | 5-year | -17.0% | +57.1% | at high | +97.8% |
| alltime | all time | -26.1% | +94.3% | -49.8% | +108.0% |
Aquestive Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $70.46 M(+57.1%) | $20.93 M(+20.3%) |
| Sep 2024 | - | $17.39 M(+12.1%) |
| Jun 2024 | - | $15.52 M(-6.6%) |
| Mar 2024 | - | $16.62 M(+33.6%) |
| Dec 2023 | $44.85 M(-36.3%) | $12.44 M(+17.6%) |
| Sep 2023 | - | $10.58 M(-2.3%) |
| Jun 2023 | - | $10.83 M(-1.5%) |
| Mar 2023 | - | $11.00 M(-31.6%) |
| Dec 2022 | $70.36 M(-0.2%) | $16.09 M(+2.5%) |
| Sep 2022 | - | $15.69 M(-24.5%) |
| Jun 2022 | - | $20.79 M(+16.8%) |
| Mar 2022 | - | $17.79 M(-8.2%) |
| Dec 2021 | $70.52 M(-6.9%) | $19.38 M(+15.0%) |
| Sep 2021 | - | $16.86 M(-3.1%) |
| Jun 2021 | - | $17.40 M(+3.0%) |
| Mar 2021 | - | $16.89 M(-15.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $75.78 M(-10.8%) | $20.01 M(+5.0%) |
| Sep 2020 | - | $19.06 M(+7.5%) |
| Jun 2020 | - | $17.74 M(-6.5%) |
| Mar 2020 | - | $18.97 M(-2.9%) |
| Dec 2019 | $84.92 M(-11.0%) | $19.53 M(+4.0%) |
| Sep 2019 | - | $18.78 M(-23.0%) |
| Jun 2019 | - | $24.40 M(+9.8%) |
| Mar 2019 | - | $22.21 M(-8.9%) |
| Dec 2018 | $95.38 M(+102.0%) | $24.39 M(+44.5%) |
| Sep 2018 | - | $16.88 M(-59.5%) |
| Jun 2018 | - | $41.66 M(+234.1%) |
| Mar 2018 | - | $12.47 M(-9.9%) |
| Dec 2017 | $47.21 M(+30.2%) | $13.84 M(+16.8%) |
| Sep 2017 | - | $11.85 M(+17.7%) |
| Jun 2017 | - | $10.06 M(-12.3%) |
| Mar 2017 | - | $11.47 M |
| Dec 2016 | $36.25 M | - |
FAQ
- What is Aquestive Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Aquestive Therapeutics?
- What is Aquestive Therapeutics annual operating expenses year-on-year change?
- What is Aquestive Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Aquestive Therapeutics?
- What is Aquestive Therapeutics quarterly operating expenses year-on-year change?
What is Aquestive Therapeutics annual total operating expenses?
The current annual operating expenses of AQST is $70.46 M
What is the all time high annual operating expenses for Aquestive Therapeutics?
Aquestive Therapeutics all-time high annual total operating expenses is $95.38 M
What is Aquestive Therapeutics annual operating expenses year-on-year change?
Over the past year, AQST annual total operating expenses has changed by +$25.61 M (+57.09%)
What is Aquestive Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of AQST is $20.93 M
What is the all time high quarterly operating expenses for Aquestive Therapeutics?
Aquestive Therapeutics all-time high quarterly total operating expenses is $41.66 M
What is Aquestive Therapeutics quarterly operating expenses year-on-year change?
Over the past year, AQST quarterly total operating expenses has changed by $0.00 (0.00%)